Emma has been GSK CEO and Board Director since April 2017. Emma has been a member of the GSK Leadership Team since 2011, as the President and then CEO of GSK Consumer Healthcare. She chaired the Consumer Joint Venture with Pfizer until its demerger as Haleon in 2022.
Prior to joining GSK in 2010, Emma worked with L’Oreal for 17 years in global and local marketing and general management roles in Paris, London, New York and Shanghai.
Emma joined the Microsoft board as an independent director in 2019. She is a member of the Stanford Medicine Board of Fellows and a member of The Business Council Executive Committee in the US. She was previously a Non-Executive Director of Diageo.
Emma was appointed Dame Commander of the British Empire for services to the pharmaceutical industry and business in 2020.
Emma holds an MA in Classics and Modern Languages from Oxford University.
Follow Emma on:
